The PiPS (Probiotics in Preterm Infants Study) Trial - Controlling the Confounding Factor of Cross-contamination Unveils Significant Benefits

Indian pediatrics

Volumn 54, Issue 2, 2017, Pages 162-

  Karthikeyan, G ^a   Bhat, B Vishnu ^b  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; PROBIOTIC AGENT;

HUMAN; INFANT; NECROTIZING ENTEROCOLITIS; NEWBORN; PREMATURITY;

ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; METHOTREXATE; PROBIOTICS;

EID: 85028314961     PISSN: None     EISSN: 09747559     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)